Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 7971842, 10 pages
https://doi.org/10.1155/2018/7971842
Research Article

Galangin and Pinocembrin from Propolis Ameliorate Insulin Resistance in HepG2 Cells via Regulating Akt/mTOR Signaling

1Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China
2College of Food Engineering, Harbin University of Commerce, Harbin 150076, China
3National Research Center of Bee Product Processing, Ministry of Agriculture, Beijing 100093, China

Correspondence should be addressed to Wenjun Peng; moc.anis.piv@nujnewgnep and Hongcheng Zhang; moc.qq@478414064

Received 10 July 2018; Accepted 16 October 2018; Published 21 October 2018

Academic Editor: Nunziatina De Tommasi

Copyright © 2018 Yinkang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Ogurtsova, J. D. da Rocha Fernandes, Y. Huang et al., “IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040,” Diabetes Research and Clinical Practice, vol. 128, pp. 40–50, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Jug, M. Z. Končić, and I. Kosalec, “Modulation of antioxidant, chelating and antimicrobial activity of poplar chemo-type propolis by extraction procures,” LWT- Food Science and Technology, vol. 57, no. 2, pp. 530–537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Usman, “Effect of bees propolis on fasting blood sugar and its antioxidant properties in diabetic rats,” FASEB J, p. 28, 2014. View at Google Scholar
  4. K. Wang, J. L. Zhang, S. Ping, Q. X. Ma, and X. Chen, “Anti-inflammatory effects of ethanol extracts of Chinese propolis and buds from poplar (Populus×canadensis),” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 300–311, 2014. View at Publisher · View at Google Scholar
  5. Y. Wang, C. Fu, L. Zhang, Z. Li, F. Zhang, and H. Xuan, Anti-tumor Effect of Chinese Propolis and Brazilian propolis, Apiculture of China, 2014.
  6. Y. Li, M. Chen, H. Xuan, and F. Hu, “Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evidence-based complementary and alternative medicine,” in Effects of encapsulated propolis on blood glycemic control, vol. 2012, 2012. View at Google Scholar
  7. K. Hiroshi, N. Yoshinori, K. Shunsuke, M. Tomomi, O. Shiki, T. Chitoku et al., “Beneficial effects of Brazilian propolis on type 2 diabetes inob/obmice,” Adipocyte, vol. 2, no. 4, p. 227, 2013. View at Google Scholar
  8. I. Cordero-Herrera, M. Á. Martín, L. Goya, and S. Ramos, “Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells,” Food and Chemical Toxicology, vol. 64, pp. 10–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Q.-Y. Zhang, Y. Pan, R. Wang et al., “Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats,” The Journal of Nutritional Biochemistry, vol. 25, no. 4, pp. 420–428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. W. Jung, K.-T. Lee, M. W. Lee, and K.-H. Ka, “SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150,” Biochemical and Biophysical Research Communications, vol. 422, no. 2, pp. 229–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-J. Song, Q. Wang, M. Du, B. Chen, and X.-Y. Mao, “Peptide IPPKKNQDKTE ameliorates insulin resistance in HepG2 cells via blocking ROS-mediated MAPK signaling,” Journal of Functional Foods, vol. 31, pp. 287–294, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. K. E. O'Reilly, F. Rojo, Q.-B. She et al., “mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt,” Cancer Research, vol. 66, no. 3, pp. 1500–1508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. V. Haar, S. I. Lee, S. Bandhakavi, T. J. Griffin, and D.-H. Kim, “Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40,” Nature Cell Biology, vol. 9, no. 3, pp. 316–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. O. A. J. Adegoke, H. E. Bates, M. A. Kiraly, M. Vranic, M. C. Riddell, and E. B. Marliss, “Exercise in ZDF rats does not attenuate weight gain, but prevents hyperglycemia concurrent with modulation of amino acid metabolism and AKT/mTOR activation in skeletal muscle,” European Journal of Nutrition, vol. 54, no. 5, pp. 751–759, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Yang, Y. Cheng, P. Li et al., “A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis,” Tumor Biology, vol. 36, no. 1, pp. 383–391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Porta, C. Paglino, and A. Mosca, “Targeting PI3K/Akt/mTOR signaling in cancer,” Frontiers in Oncology, vol. 4, article 64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-H. Liu, Z. Dong, J.-M. Fu, and F.-X. Zeng, “Effects of batephrine on insulin resistance in HepG2 cells and its mechanism,” Chinese Journal of New Drugs, vol. 17, no. 12, pp. 1026–1029, 2008. View at Google Scholar · View at Scopus
  18. Q. Chen, Y.-P. Xia, and Z.-Y. Qiu, “Effects of ecdysterone on insulin sensitivity and glucose metabolism in insulin-resistant cell model,” Chinese Pharmacological Bulletin, vol. 22, no. 4, pp. 460–464, 2006. View at Google Scholar · View at Scopus
  19. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Trott and A. J. Olson, “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading,” Journal of Computational Chemistry, vol. 31, no. 2, pp. 455–461, 2010. View at Publisher · View at Google Scholar
  21. K.-T. Chen, M.-J. Hour, S.-C. Tsai et al., “The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino) quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor,” International Journal of Oncology, vol. 39, no. 3, pp. 611–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Jia, D. Zheng, L. Zhang et al., “Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene,” Endocrine Journal, vol. 65, no. 6, pp. 645–655, 2018. View at Publisher · View at Google Scholar
  23. G. M. Morris, H. Ruth, W. Lindstrom et al., “Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility,” Journal of Computational Chemistry, vol. 30, no. 16, pp. 2785–2791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. F. Sanner, “Python, a programming language for software integration and development,” J Mol Graph Model, vol. 17, no. 1, p. 57, 1999. View at Google Scholar
  25. I. Cordero-Herrera, M. Á. Martín, F. Escrivá, C. álvarez, L. Goya, and S. Ramos, “Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats,” The Journal of Nutritional Biochemistry, vol. 26, no. 7, pp. 704–712, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Y. Jung, Y. Lim, M. S. Moon, J. Y. Kim, and O. Kwon, “Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats,” Nutrition & Metabolism, vol. 8, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-N. Jin, G.-R. Shi, S.-A. Tang, Nan-Qin, W. Qiao, and H.-Q. Duan, “Flavonoids from Tetrastigma obtectum enhancing glucose consumption in insulin-resistance HepG2 cells via activating AMPK,” Fitoterapia, vol. 90, pp. 240–246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Aoi, S. Hosogi, N. Niisato et al., “Improvement of insulin resistance, blood pressure and interstitial pH in early developmental stage of insulin resistance in OLETF rats by intake of propolis extracts,” Biochemical and Biophysical Research Communications, vol. 432, no. 4, pp. 650–653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. U. J. Jung, M.-K. Lee, Y. B. Park, M. A. Kang, and M.-S. Choi, “Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice,” The International Journal of Biochemistry & Cell Biology, vol. 38, no. 7, pp. 1134–1145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zheng, Y. Ke, A. Feng et al., “The mechanism by which amentoflavone improves insulin resistance in HepG2 Cells,” Molecules, vol. 21, no. 5, 2016. View at Google Scholar · View at Scopus
  31. X. Hu, S. Wang, J. Xu, D.-B. Wang, Y. Chen, and G.-Z. Yang, “Triterpenoid saponins from Stauntonia chinensis ameliorate insulin resistance via the AMP-activated protein kinase and IR/IRS-1/PI3K/Akt pathways in insulin-resistant HepG2 cells,” International Journal of Molecular Sciences, vol. 15, no. 6, pp. 10446–10458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. S. Sivakumar, P. Viswanathan, and C. V. Anuradha, “Dose-dependent effect of galangin on fructose-mediated insulin resistance and oxidative events in rat kidney,” Redox Report, vol. 15, no. 5, pp. 224–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Paz, R. Hemi, D. LeRoith et al., “A Molecular Basis for Insulin Resistance,” The Journal of Biological Chemistry, vol. 272, no. 47, pp. 29911–29918, 1997. View at Publisher · View at Google Scholar
  34. K. Egawa, H. Maegawa, S. Shimizu et al., “Protein-tyrosine Phosphatase-1B Negatively Regulates Insulin Signaling in L6 Myocytes and Fao Hepatoma Cells,” The Journal of Biological Chemistry, vol. 276, no. 13, pp. 10207–10211, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Oku, M. Nawano, K. Ueta et al., “Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle,” American Journal of Physiology-Endocrinology and Metabolism, vol. 280, no. 5, pp. E816–E824, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. R. J. Perry, V. T. Samuel, K. F. Petersen, and G. I. Shulman, “The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes,” Nature, vol. 510, no. 7503, pp. 84–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Lee and M.-S. Kim, “The role of GSK3 in glucose homeostasis and the development of insulin resistance,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. S49–S57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. K. H. Khan, M. Wong, K. Rihawi et al., “Hyperglycemia and phosphatidylinositol 3-kinase/protein kinase B/Mammalian target of rapamycin (PI3K/AKT/mTOR) Inhibitors in phase I trials: Incidence, predictive factors, and management,” The Oncologist, vol. 21, no. 7, pp. 855–860, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Tzatsos and K. V. Kandror, “Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation,” Molecular and Cellular Biology, vol. 26, no. 1, pp. 63–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Magnuson, B. Ekim, and D. C. Fingar, “Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks,” Biochemical Journal, vol. 441, no. 1, pp. 1–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Fu, H. Cui, and Y. Zhang, “Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease,” Cellular Physiology & Biochemistry International Journal of Experimental Cellular Physiology Biochemistry & Pharmacology, vol. 45, no. 6, p. 2187, 2018. View at Google Scholar